-transparent.png){kind=logo}
Adriamycin and mitomycin C in combination have been tested in the treatment of advanced breast cancer. In an initial pilot study 11 heavily pretreated patients received mitomycin C alone and 2 (18%) achieved partial responses. Subsequently, 27 patients who had not received prior chemotherapy for advanced breast cancer were treated with adriamycin 40 mg/m2 + mitomycin C 10 mg/m2 i.v. every 3 weeks. Six (22%) achieved complete and 10 (37%) achieved partial responses, giving an objective regression frequency of 59%. The median duration of response was 37 weeks (range 8-55+ weeks).
Related Publications
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
January 1986,
Cancer chemotherapy and pharmacology,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
September 1981,
Cancer,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
April 1983,
Gan to kagaku ryoho. Cancer & chemotherapy,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
July 1985,
Gan to kagaku ryoho. Cancer & chemotherapy,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
December 1985,
Gan to kagaku ryoho. Cancer & chemotherapy,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
June 1988,
Seminars in oncology,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
June 1990,
Tumori,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
March 1986,
Cancer,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
January 1988,
Medical oncology and tumor pharmacotherapy,
S A Amiel, and
J F Stewart, and
H M Earl, and
R K Knight, and
R D Rubens
January 1991,
Bulletin du cancer,
